Drug class
Antitussives (Opioid Antitussives and DM)
The phrase "Antitussives (Opioid Antitussives and DM)" represents a combined functional category rather than a single standardized pharmacological class, grouping centrally acting opioid suppressants—principally codeine and hydrocodone—with dextromethorphan (DM), a synthetic morphinan derivative. Read more about Antitussives (Opioid Antitussives and DM)
1,151 drugs in this class 155 manufacturers
Drugs in Antitussives (Opioid Antitussives and DM)
BROMPHENIRAMINE-PSEUDOEPHED-DM (brompheniramine maleate/pseudoephedrine HCl/dextromethorphan)
TUSSIN CF MAX MULTI-SYMPTOM (guaifenesin/dextromethorphan hydrobromide/acetaminophen)
CHLORPAP PEH DM (chlorpheniramine maleate/phenylephrine HCl/dextromethorphan)
TUSSIN CF SEVERE MULTI-SYMPTOM (guaifenesin/dextromethorphan hydrobromide/acetaminophen)
TUSSIN DM MAX (guaifenesin/dextromethorphan HBr)
CHLOR A-HIST DM (chlorpheniramine maleate/phenylephrine HCl/dextromethorphan)
MUCUS RELIEF DM MAX ER (guaifenesin/dextromethorphan HBr)
MEDI-MUCUS (guaifenesin/dextromethorphan HBr)
The phrase "Antitussives (Opioid Antitussives and DM)" represents a combined functional category rather than a single standardized pharmacological class, grouping centrally acting opioid suppressants—principally codeine and hydrocodone—with dextromethorphan (DM), a synthetic morphinan derivative.
These agents act primarily within the central nervous system to elevate the cough reflex threshold in the brainstem, with opioids stimulating central mu-opioid receptors and dextromethorphan exerting non-opioid antitussive effects largely via sigma-1 receptor agonism and NMDA receptor antagonism.
Clinically, medications in this grouping are indicated for the short-term, symptomatic suppression of nonproductive cough associated with acute upper respiratory tract infections, allergies, and bronchitis.
-
fda.gov
The phrase "Antitussives (Opioid Antitussives and DM)" represents a combined functional category rather than a single standardized pharmacological class, grouping centrally acting opioid suppressants—principally codeine and hydrocodone—with dextromethorphan (DM), a synthetic morphinan derivative These agents act primarily within the central nervous system to elevate the cough reflex threshold in the brainstem, with opioids stimulating central mu-opioid receptors and dextromethorphan exerting non...
-
fda.gov
The phrase "Antitussives (Opioid Antitussives and DM)" represents a combined functional category rather than a single standardized pharmacological class, grouping centrally acting opioid suppressants—principally codeine and hydrocodone—with dextromethorphan (DM), a synthetic morphinan derivative
-
drugbank.com
The phrase "Antitussives (Opioid Antitussives and DM)" represents a combined functional category rather than a single standardized pharmacological class, grouping centrally acting opioid suppressants—principally codeine and hydrocodone—with dextromethorphan (DM), a synthetic morphinan derivative These agents act primarily within the central nervous system to elevate the cough reflex threshold in the brainstem, with opioids stimulating central mu-opioid receptors and dextromethorphan exerting non...
-
nih.gov
These agents act primarily within the central nervous system to elevate the cough reflex threshold in the brainstem, with opioids stimulating central mu-opioid receptors and dextromethorphan exerting non-opioid antitussive effects largely via sigma-1 receptor agonism and NMDA receptor antagonism
-
nih.gov
Clinically, medications in this grouping are indicated for the short-term, symptomatic suppression of nonproductive cough associated with acute upper respiratory tract infections, allergies, and bronchitis
Sign in to follow this class
Following a drug class requires a free Physicians Office Resource account.